European Journal of Cancer
Volume 38, Issue 14 , Pages 1927-1936 , September 2002

RhCG is downregulated in oesophageal squamous cell carcinomas, but expressed in multiple squamous epithelia

Received 1 February 2002 ,Revised 11 April 2002 ,Accepted 7 June 2002.

References 

  1. Day NE, Munoz N. Esophagus. In Cancer Epidemiology and Prevention. Schottenfeld D, Fraumeni JF, Jr. W. B. Saunders Company, Philadelphia, 1982, 596–623.
  2. Lu SH, Ohshima H, Fu HM, et al.  Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of the high and low-risk areas for esophageal cancer in North China: endogenous formation of nitrosoproline and its inhibition by vitamin C. Cancer Res. 1986;46:1485–1491
  3. Li JY, Taylor PR, Li B, et al.  Nutrition intervention trials in Lixian, China: multiple vitamine/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst. 1993;85:1492–1498
  4. Hu N, Dawsey SM, Wu M, et al.  Familial aggregation of esophageal cancer in Yangcheng county, Shanxi province, China. Int. Epidemiol. Assoc. 1992;21:817–822
  5. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J. Natl. Cancer Inst. 1992;84:771–776
  6. Li WD, Wang XQ, Zhang C, et al.  Genetic epidemiology investigation of esophageal cancer in Yangchuan, Shanxi province. Chin. J. Med. 1998;78:203–206
  7. Xu ZX, Wang MR, Xu X, et al.  MAL gene is down-regulated dramatically in human esophageal cancer. Chin. J. Oncol. 1999;21:250–252
  8. Wu KM, Xu ZX, Wang MR, et al.  Cloning and expression analysis of down-regulated cDNA C6–2A in human esophageal cancer. Chin. J. Med. Gene. 1999;16:325–327
  9. Chen BS, Wang MR, Cai Y, et al.  Dcreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis. 2000;21:2147–2150
  10. Chen BS, Wang MR, Xu X, et al.  Transglutaminase-3, an esophageal cancer-related gene. Int J. Cancer. 2000;88:862–865
  11. Liu Z, Chen Y, Mo R, et al.  Characterization of human RhCG and mouse Rhcg as novel nonerythroid Rh glycoprotein homologues predominantly expressed in kidney and testis. J. Biol. Chem. 2000;275:25641–25651
  12. Cherif-Zahar B, Matassi G, Raynal V, et al.  Rh-dificiency of the regulator type caused by splicing mutations in the human RH50 gene. Blood. 1998;92:2535–2540
  13. Hyland CA, Cherif-Zahar B, Cowley N, et al.  A novel single missense mutation identified along the RH50 gene in a composite heterozygous Rhnull blood donor of the regulator type. Blood. 1998;91:1458–1463
  14. Huang CH. The human Rh50 glycoprotein gene: structural organization and associated splicing defect resulting in Rhnull disease. J. Biol. Chem. 1998;273:2207–2213
  15. Huang CH, Chen Y, Reid ME, Seidl C. Rhnull disease: the amorph type results from a novel double mutation in RhCE gene on D-negative background. Blood. 1998;92:664–671
  16. Huang CH, Liu Z, Cheng GJ, Chen Y. Rh50 glycoprotein gene and Rhnull disease (a silent splice donor is trans to a Gly279→Glu missense mutation in the conserved transmembrane segment). Blood. 1998;92:1776–1784
  17. Huang CH, Cheng GJ, Reid ME, Chen Y. Rhmod syndrome (a family study of the translation-initiator mutation in the Rh50 glycoprotein gene). Am. J. Hum. Genet. 1999;64:108–117
  18. Nash R, Shojania AM. Hematological aspect of Rh deficiency syndrome (a case report and a review of the literature). Am. J. Hematol. 1987;24:267–275
  19. Avent ND, Reid ME. The Rh blood group system (a review). Blood. 2000;1995:375–387
  20. Wilson R, Ainscough R, Anderson K, et al.  2.2Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 1994;368:32–38
  21. Seack J, Pancer Z, Muller IM, Muller WE. Molecular cloning and primary structure of a Rhesus (Rh)-like protein from the marine sponge Geodia cydonium. Immunogenetics. 1997;46:493–498
  22. Wang XQ, Xiao F, Wang MR, Zhou CN, Wu M. Establishment and chromosome analysis of two human esophageal cancer cell lines. Chin. J. Oncol. 1998;20:354–356
  23. Xiao F, Wang X, Wang MR, Guan XY, Wu M. Molecular cytogenetic study on four human esophageal cancer cell lines. Chin. J. Med. Genet. 1998;15:75–77
  24. Simon HG, Oppenheimer S. Advanced mRNA differential display: isolation of a new differential regulated myosin heavy chain-encoding gene in amphibian limb regeneration. Gene. 1996;172:175–181
  25. Zhu D, Wang L, Wu M. Screening for point mutations of p53 gene in esophageal cancer by PCR-SSCP silver staining method. Chin. J. Med. Genet. 1994;11:354–355
  26. Lu SH, Ohshima H, Fu HM, et al.  Urinary excretion of N-notrosamino acids and nitrate by inhabitants of the high and low-risk areas for esophageal cancer in North China (endogenous formation of nitrosoproline and its inhibition by vitamin C). Cancer Res. 1986;46:1485–1491
  27. Li JY, Taylor PR, Li B, et al.  Nutrition intervention trials in Lixian, China (multiple vitamine/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia). J. Natl. Cancer Inst. 1993;85:1492–1498
  28. Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus. Med. Rev. 1990;4:47–55
  29. Westhoff CM, Ferreri-Jacobia M, Mak DO, Foskett JK. Identification of the erythrocyte Rh-blood group glycoprotein as a mammalian ammonium transporter. J. Biol. Chem. 2002;277:12249–12502
  30. Marini AM, Urrestarazu A, Beauwens R, Andre B. The Rh (Rhesus) blood group polypeptides are related to NH4+ transporters. Trends Biochem. Sci. 1997;22:460–461

PII: S0959-8049(02)00190-9

European Journal of Cancer
Volume 38, Issue 14 , Pages 1927-1936 , September 2002

Article Tools

* Image Usage & Resolution